Premium
Phase I study of escalating doses of carfilzomib with HyperCVAD in patients with newly diagnosed acute lymphoblastic leukemia
Author(s) -
Jonas Brian A.,
Fisch Samantha C.,
Rosenberg Aaron S.,
Hoeg Rasmus T.,
Tuscano Joseph M.,
Abedi Mehrdad
Publication year - 2021
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26105
Subject(s) - medicine , carfilzomib , bortezomib , vincristine , oncology , cytarabine , regimen , cyclophosphamide , proteasome inhibitor , rituximab , multiple myeloma , pharmacology , chemotherapy , lymphoma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom